Immunome director Isaac Barchas reports disposal of common shares worth $2.18 million

Reuters2026/08/12 21:48

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Immunome director Isaac Barchas reported selling 83,464 common shares across Aug. 10-12, 2026.
Sales included 72,416 shares held indirectly, sold at weighted average prices of USD 26.07 and USD 26.23.
Barchas also sold 11,048 shares directly at USD 27.25.
Directly held stake rose to 92,211 shares following the Aug. 12 sale.
Indirect holdings fell to zero following the Aug. 11 sale.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunome Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001808343-26-000010), on August 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Immunome director Isaac Barchas reports disposal of common shares worth $2.18 million

You may also like

Crypto prices